Qlucore AB (publ) (NOVKAN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.411x

Based on the latest financial reports, Qlucore AB (publ) (NOVKAN) has a cash flow conversion efficiency ratio of -0.411x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.19 Million ≈ $-666.47K USD) by net assets (Skr15.06 Million ≈ $1.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Qlucore AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Qlucore AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Qlucore AB (publ) for a breakdown of total debt and financial obligations.

Qlucore AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qlucore AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sadot Group Inc. NASDAQ:SDOT	-0.042x
LogicMark Inc NASDAQ:LGMK	-0.081x
Elixxer Ltd V:ELXR	0.024x
Rajvir Industries Limited NSE:RAJVIR	-0.158x
AdCapital AG F:ADC	N/A
Dewhurst plc LSE:DWHA	0.062x
Eden Research plc LSE:EDEN	-0.048x
Mitra Komunikasi Nusantara Tbk PT JK:MKNT	-0.463x

Annual Cash Flow Conversion Efficiency for Qlucore AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Qlucore AB (publ) from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Qlucore AB (publ) stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr15.06 Million ≈ $1.62 Million	Skr-30.29 Million ≈ $-3.26 Million	-2.011x	-114.02%
2024-12-31	Skr62.30 Million ≈ $6.70 Million	Skr-58.53 Million ≈ $-6.30 Million	-0.940x	+19.56%
2023-12-31	Skr47.66 Million ≈ $5.13 Million	Skr-55.67 Million ≈ $-5.99 Million	-1.168x	-162.54%
2022-12-31	Skr106.91 Million ≈ $11.51 Million	Skr-47.56 Million ≈ $-5.12 Million	-0.445x	-23.54%
2021-12-31	Skr122.54 Million ≈ $13.19 Million	Skr-44.12 Million ≈ $-4.75 Million	-0.360x	+33.24%
2020-12-31	Skr72.28 Million ≈ $7.78 Million	Skr-38.99 Million ≈ $-4.20 Million	-0.539x	+71.77%
2019-12-31	Skr17.42 Million ≈ $1.87 Million	Skr-33.29 Million ≈ $-3.58 Million	-1.911x	-41.51%
2018-12-31	Skr33.36 Million ≈ $3.59 Million	Skr-45.04 Million ≈ $-4.85 Million	-1.350x	+2.37%
2017-12-31	Skr38.71 Million ≈ $4.17 Million	Skr-53.54 Million ≈ $-5.76 Million	-1.383x	-256.36%
2016-12-31	Skr59.52 Million ≈ $6.41 Million	Skr-23.10 Million ≈ $-2.49 Million	-0.388x	+58.81%
2015-12-31	Skr21.93 Million ≈ $2.36 Million	Skr-20.66 Million ≈ $-2.22 Million	-0.942x	-34.58%
2014-12-31	Skr27.29 Million ≈ $2.94 Million	Skr-19.11 Million ≈ $-2.06 Million	-0.700x	-99.93%
2013-12-31	Skr18.96 Million ≈ $2.04 Million	Skr-6.64 Million ≈ $-714.35K	-0.350x	+92.89%
2012-12-31	Skr5.50 Million ≈ $591.78K	Skr-27.08 Million ≈ $-2.91 Million	-4.925x	-449.52%
2011-12-31	Skr25.90 Million ≈ $2.79 Million	Skr-23.21 Million ≈ $-2.50 Million	-0.896x	-75.76%
2010-12-31	Skr11.07 Million ≈ $1.19 Million	Skr-5.64 Million ≈ $-607.38K	-0.510x	--

About Qlucore AB (publ)

ST:NOVKAN USA Biotechnology

Market Cap

$326.04K

Skr3.03 Million SEK

Market Cap Rank

#30885 Global

#6075 in USA

Share Price

Skr0.03

Change (1 day)

-43.95%

52-Week Range

Skr0.03 - Skr0.23

All Time High

Skr0.23